Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.

Allan-Blitz, Lao-Tzu; Klausner, Jeffrey D

Allan-Blitz, Lao-Tzu; Klausner, Jeffrey D.

Allan-Blitz LT; Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Klausner JD; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

J Infect Dis ; 224(3): 556-557, 2021 08 02.

Article in English | MEDLINE | ID: covidwho-1390356

Subject(s)

COVID-19; Epidemics; Humans; New York City/epidemiology; SARS-CoV-2; Seroepidemiologic Studies; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epidemics / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google